Postischemic liver damage in rats: effect of some therapeutic interventions on survival rate.

Postischemic liver damage in rats: effect of some therapeutic interventions on survival rate.
复制标题

DOI:
10.1620/tjem.138.63
复制
发表时间:
1982-09
期刊:
The Tohoku journal of experimental medicine
影响因子:
--
通讯作者:
H. Yamauchi;I. Baća;U. Mittmann;H. Geisen;M. Salzer
H. Yamauchi;I. Baća;U. Mittmann;H. Geisen;M. Salzer
中科院分区:
其他
文献类型:
--
作者:
H. Yamauchi;I. Baća;U. Mittmann;H. Geisen;M. Salzer

文献摘要

被引文献

相似文献

本文旨在阐明常温下肝脏部分(2/3)缺血90分钟后死亡的原因,并检查胰高血糖素、生长抑素、胰岛素、泼尼松龙和口服多粘菌素B(PB)的作用。将部分缺血90分钟后24小时的动物分为两组,即外观正常的动物和濒死状态的动物。两组大鼠的血浆S-GOT、S-GPT、氨基酸、NH3或胰岛素水平或坏死肝细胞的形态学估计体积比均无显著差异。然而,濒死大鼠的血糖水平显著降低(31 +/- 28 mg/100 ml,n = 6),与外观正常的大鼠(149 +/- 19,n = 5)相比,鲎凝胶试验阳性发生率更高。动物的1天和1周存活率分别为42/62(69%)和32/61(53%)。胰高血糖素注射液(1.5 mg/kg,缺血后)可有效提高1天存活率(14/14),但未能提高1周存活率(11/14)。另一方面,生长抑素注射液(100微克/公斤,缺血后)或PB治疗(15毫克/公斤/天× 5-9,缺血前)成功地增加了1周的生存率(20/22 p小于0.01和17/17 p小于0.01,分别),虽然转氨酶水平或坏死体积比没有显着改善。可以看出,部分缺血后的濒死状态伴随着严重的低血糖休克,缺血后注射生长抑素或缺血前口服多粘菌素B消灭革兰氏阴性菌可防止低血糖休克的发生。
The aim of this paper is to elucidate the cause of death after 90 min of normothermic partial (2/3) ischemia of the liver and to examine the effects of glucagon, somatostatin, insulin, prednisolone and oral administration of polymyxin B (PB). The animals 24 hr after partial ischemia for 90 min were divided into two groups; namely, animals with normal appearance and those with moribund state. There were no significant differences in the plasma level of S-GOT, S-GPT, amino acids, NH3 or insulin, or in morphometrically estimated volume ratio of necrotic hepatocytes between the two groups of rats. The blood glucose level, however, was significantly decreased (31 +/- 28 mg/100 ml, n = 6) in the moribund rats with a higher incidence of positive Limulus gelation tests as compared with the rats with normal appearance (149 +/- 19, n = 5). The 1-day and 1-week survival rates of the animals were 42/62 (69%) and 32/61 (53%), respectively. A glucagon injection (1.5 mg/kg, after ischemia) was effective to elevate the 1-day survival rate (14/14), but failed to increase the 1-week survival rate (11/14). On the other hand, a somatostatin injection (100 micrograms/kg, after ischemia) or PB treatment (15 mg/kg/day x 5-9, before ischemia) succeeded to increase the 1-week survival rate (20/22 p less than 0.01 and 17/17 p less than 0.01, respectively), although no significant amelioration in transaminase levels or volume ratio of necrosis was demonstrated. It could be seen that a moribund state after partial ischemia was accompanied by severe hypoglycemic shock, and that the injection of somatostatin after ischemia or the annihilation of gram-negative bacteria by means of oral administration of polymyxin B before ischemia prevented the occurrence of the hypoglycemic shock.